Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Same Pill, Different Impact - Reassessing the Efficacy of Nirmatrelvir-Ritonavir.

The New England journal of medicine·2026

Same author

Treatment and prevention of HIV/AIDS: Unfinished business.

PLoS medicine·2025

Same author

Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health Collaboration.

JAMA network open·2025

Same author

Reflection on the Legacy of Lawrence Gostin in Global Health.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025

Same author

The importance of ClinicalTrials.gov in informing trial design, conduct, and results.

Journal of clinical and translational science·2025

Same author

HIV/AIDS and COVID-19: Shared Lessons From 2 Pandemics.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Search research articles

Related Experiment Video

Updated: Mar 14, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

Considerations for Developing a Zika Virus Vaccine

Hilary D Marston¹, Nicole Lurie¹, Luciana L Borio¹

¹From the National Institute of Allergy and Infectious Diseases, Bethesda (H.D.M., A.S.F.), and the Office of the Commissioner, Food and Drug Administration, Silver Spring (L.L.B) - both in Maryland; and the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (N.L.).

The New England Journal of Medicine

|September 30, 2016

Summary

No abstract available in PubMed .

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

Related Experiment Videos

Last Updated: Mar 14, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019